Clonal lymphoproliferation following chronic active Epstein-Barr virus infection and hypersensitivity to mosquito bites

被引:0
|
作者
Ishihara, S
Okada, S
Wakiguchi, H
Kurashige, T
Hirai, K
KawaHa, K
机构
[1] OSAKA UNIV, FAC MED, DEPT PEDIAT, SUITA, OSAKA, JAPAN
[2] KOHCHI MED SCH, DEPT PEDIAT, NANKOKU, KOCHI, JAPAN
[3] TOKYO MED & DENT UNIV, MED RES INST, DEPT VIROL & IMMUNOL, BUNKYO KU, TOKYO, JAPAN
[4] OSAKA MED CTR, DEPT PEDIAT, IZUMI, OSAKA, JAPAN
[5] MATERNAL & CHILD HLTH RES INST, IZUMI, OSAKA, JAPAN
关键词
Epstein-Barr virus (EBV); chronic active Epstein-Barr virus infection (CAEBV); lymphoproliferative disease (LPD); hypersensitivity to mosquito bites (HMB);
D O I
10.1002/(SICI)1096-8652(199704)54:4<276::AID-AJH3>3.0.CO;2-S
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
In order to elucidate the possibility of lymphoproliferation in cases of chronic active Epstein-Barr virus infection (CAEBV), to clarify the clonality and genotype of proliferating lymphocytes, and to search for the factors that induce lymphoproliferation, we studied 11 cases of CAEBV, using genetical and immunological techniques. Epstein-Barr virus (EBV) DNA in peripheral mononuclear cells was detected in eight cases by Southern blotting. Among those eight cases, monoclonal proliferation of EBV DNA-positive cells was observed in three cases and oligoclonal proliferation In three cases, In the cases of monoclonal proliferation, one case manifested T-cell lymphoproliferation and the rest natural killer (NK) cell lymphoproliferation, The anti-EBV antibody titers in the study did not have any relativity to lymphoproliferation. Bn the other hand, three of the four cases of NK cell lymphoproliferation and one of the two cases of T-cell lymphoproliferation exhibited hypersensitivity to mosquito bites (HMB) in their clinical histories, while none of the three nonlymphoproliferation cases did. These facts indicate that T-cell and NK cell lymphoproliferative diseases (LPDs) could be more closely associated with EBV infection than we had previously expected. Also, the anti-EBV antibody titers may not be the indicator of EBV-associated LPD, and HMB may be one of the factors that induce EBV-associated LPD. (C) 1997 Wiley-Liss, Inc.
引用
收藏
页码:276 / 281
页数:6
相关论文
共 50 条
  • [41] Hypersensitivity to mosquito bites with natural-killer cell lymphocytosis: the possible implication of Epstein-Barr virus reactivation
    Satoh, M
    Oyama, N
    Akiba, H
    Ohtsuka, M
    Iwatsuki, K
    Kaneko, F
    EUROPEAN JOURNAL OF DERMATOLOGY, 2002, 12 (04) : 381 - 384
  • [42] Survival rates and prognostic factors of Epstein-Barr virus-associated hydroa vacciniforme and hypersensitivity to mosquito bites
    Miyake, T.
    Yamamoto, T.
    Hirai, Y.
    Otsuka, M.
    Hamada, T.
    Tsuji, K.
    Morizane, S.
    Suzuki, D.
    Aoyama, Y.
    Iwatsuki, K.
    BRITISH JOURNAL OF DERMATOLOGY, 2015, 172 (01) : 56 - 63
  • [43] Opsoclonus following Epstein-Barr virus infection
    Benito-Leon, J
    Molina, JA
    Berbel, A
    Porta-Etessam, J
    JOURNAL OF NEUROLOGY, 1998, 245 (08) : 559 - 560
  • [44] Chronic active Epstein-Barr virus infection presenting as refractory chronic sinusitis
    Kitamura, Wataru
    Fujiwara, Hideaki
    Matsumura, Akifumi
    Higaki, Takaya
    Shibata, Rei
    Toji, Tomohiro
    Fujii, Soichiro
    Asada, Noboru
    Ennishi, Daisuke
    Nishimori, Hisakazu
    Fujii, Keiko
    Fujii, Nobuharu
    Matsuoka, Ken-ichi
    Yoshino, Tadashi
    Maeda, Yoshinobu
    INTERNATIONAL JOURNAL OF HEMATOLOGY, 2022, 116 (01) : 139 - 145
  • [45] Calcification in the basal ganglia with chronic active Epstein-Barr virus infection
    Morita, M
    Tsuge, I
    Matsuoka, H
    Ito, Y
    Itosu, T
    Yamamoto, M
    Morishima, T
    NEUROLOGY, 1998, 50 (05) : 1485 - 1488
  • [46] Persistent hepatitis associated with chronic active Epstein-Barr virus infection
    Yuge, A
    Kinoshita, E
    Moriuchi, M
    Ohno, Y
    Haga, H
    Moriuchi, H
    PEDIATRIC INFECTIOUS DISEASE JOURNAL, 2004, 23 (01) : 74 - 76
  • [47] Defective Epstein-Barr virus in chronic active infection and haematological malignancy
    Okuno, Yusuke
    Murata, Takayuki
    Sato, Yoshitaka
    Muramatsu, Hideki
    Ito, Yoshinori
    Watanabe, Takahiro
    Okuno, Tatsuya
    Murakami, Norihiro
    Yoshida, Kenichi
    Sawada, Akihisa
    Inoue, Masami
    Kawa, Keisei
    Seto, Masao
    Ohshima, Koichi
    Shiraishi, Yuichi
    Chiba, Kenichi
    Tanaka, Hiroko
    Miyano, Satoru
    Narita, Yohei
    Yoshida, Masahiro
    Goshima, Fumi
    Kawada, Jun-Ichi
    Nishida, Tetsuya
    Kiyoi, Hitoshi
    Kato, Seiichi
    Nakamura, Shigeo
    Morishima, Satoko
    Yoshikawa, Tetsushi
    Fujiwara, Shigeyoshi
    Shimizu, Norio
    Isobe, Yasushi
    Noguchi, Masaaki
    Kikuta, Atsushi
    Iwatsuki, Keiji
    Takahashi, Yoshiyuki
    Kojima, Seiji
    Ogawa, Seishi
    Kimura, Hiroshi
    NATURE MICROBIOLOGY, 2019, 4 (03) : 404 - 413
  • [48] Opsoclonus following Epstein-Barr virus infection
    Julián Benito-León
    José Antonio Molina
    Angel Berbel
    Jesús Porta-Etessam
    Journal of Neurology, 1998, 245 : 559 - 560
  • [49] Vidarabine therapy for severe chronic active Epstein-Barr virus infection
    Kimura, H
    Morita, M
    Tsuge, I
    Hoshino, Y
    Tanaka, N
    Ito, Y
    Morishima, T
    JOURNAL OF PEDIATRIC HEMATOLOGY ONCOLOGY, 2001, 23 (05) : 294 - 299
  • [50] Defining the elusive boundaries of chronic active Epstein-Barr virus infection
    Fernandez-Pol, Sebastian
    Silva, Oscar
    Natkunam, Yasodha
    HAEMATOLOGICA, 2018, 103 (06) : 924 - 927